With more than 40 cannabis-related patents filed, the ebbu science team has become a global leader in data-driven, lab-tested cannabinoid research. ebbu tackles consumer trust from seed to sale by focusing on these scientific disciplines:
ebbu’s superior, patented plant genetics can maximize cannabinoid output by boosting in-plant cannabinoid production and creating rare-cannabinoid-specific plants.
ebbu’s Cellular Lab grows human receptors to test pharmacological reactions to a range of cannabinoid and terpene blends. These tests drive the development and creation of custom formulations for consistent cannabis products - from medical products that could treat anxiety, pain, sleep and more to recreational products that inspire specific sensations.
ebbu conducts double-blind studies and collects data from human volunteers for consumer feedback that allow ebbu to tweak and verify its formulations.
ebbu can separate and purify cannabinoids for product development, wholesale, and R&D. This process allows us to build every product from scratch, enabling us to deliver a consistent formulation with known compounds every time.